A significant inverse correlation between Mettl3 and Smad3 expression was also identified in CD33+CD14+CD15–HLA-DRlo MO-MDSC derived from PBMC of patients with CRC (R = -0.598, n = 28) (Fig. 7A, Table S3). This evidence concerns the gene SMAD3 and colorectal carcinoma.